{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:29:38Z","timestamp":1792416578310,"version":"4.4.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jacl.2025.06.002","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T01:20:19Z","timestamp":1750209619000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["LDL cholesterol management simplified in adults\u2014Lower for longer is better: Guidance from the National Lipid Association"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6695-6070","authenticated-orcid":false,"given":"Elizabeth J.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaye-Eileen","family":"Willard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6432-1730","authenticated-orcid":false,"given":"Christie M.","family":"Ballantyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jacl.2025.06.002_bib0001","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12916-024-03527-4","article-title":"Comparative analysis of atherosclerotic cardiovascular disease burden between ages 20\u201354 and over 55 years: insights from the Global Burden of Disease Study 2019","volume":"22","author":"Li","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.jacl.2025.06.002_bib0002","article-title":"Triglyceride-rich lipoproteins and cardiovascular diseases","volume":"15","author":"Xu","year":"2024","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.jacl.2025.06.002_bib0003","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/cpt.1125","article-title":"LDL-cholesterol is the only clinically relevant biomarker for atherosclerotic cardiovascular disease (ASCVD) risk","volume":"104","author":"Ofori-Asenso","year":"2018","journal-title":"Clin Pharmacol Therap"},{"issue":"25","key":"10.1016\/j.jacl.2025.06.002_bib0004","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2025.06.002_bib0005","first-page":"235","article-title":"The importance of low-density lipoprotein cholesterol measurement and control as performance measures: a joint clinical perspective from the National Lipid Association and the American Society for Preventive Cardiology","volume":"13","author":"Virani","year":"2023","journal-title":"Am J Prevent Cardiol"},{"issue":"9","key":"10.1016\/j.jacl.2025.06.002_bib0006","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1001\/jamacardio.2018.2258","article-title":"Efficacy and safety of further lowering of low-density lipoprotein cholesterol in patients starting with very low levels: a meta-analysis","volume":"3","author":"Sabatine","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"22","key":"10.1016\/j.jacl.2025.06.002_bib0007","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1093\/eurheartj\/ehaa1080","article-title":"How low is safe? The frontier of very low (<30 Mg\/dL) LDL cholesterol","volume":"42","author":"Karagiannis","year":"2021","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.jacl.2025.06.002_bib0008","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics\u20142019 update: a report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jacl.2025.06.002_bib0009","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1016\/j.jacl.2024.08.013","article-title":"Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: an expert clinical consensus from the National Lipid Association","volume":"18","author":"Soffer","year":"2024","journal-title":"J Clin Lipidol"},{"issue":"12","key":"10.1016\/j.jacl.2025.06.002_bib0010","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis","volume":"316","author":"Silverman","year":"2016","journal-title":"Jama"},{"issue":"5","key":"10.1016\/j.jacl.2025.06.002_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2015.05.006","article-title":"Universal cholesterol screening of children in community-based ambulatory pediatric clinics","volume":"9","author":"Wilson","year":"2015","journal-title":"J Clin Lipidol"},{"issue":"14","key":"10.1016\/j.jacl.2025.06.002_bib0012","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jacc.2022.07.006","article-title":"2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"80","author":"Lloyd-Jones","year":"2022","journal-title":"JACC"},{"key":"10.1016\/j.jacl.2025.06.002_bib0013","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10545-013-9665-4","article-title":"Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management","volume":"37","author":"Lee","year":"2014","journal-title":"J Inherit Metab Dis"},{"issue":"8","key":"10.1016\/j.jacl.2025.06.002_bib0014","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/iub.2662","article-title":"Central nervous system cholesterol metabolism in health and disease","volume":"74","author":"Ho","year":"2022","journal-title":"IUBMB Life"},{"issue":"2","key":"10.1016\/j.jacl.2025.06.002_bib0015","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3390\/pharmaceutics16020214","article-title":"Potential benefits and risks associated with the use of statins","volume":"16","author":"Khatiwada","year":"2024","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.jacl.2025.06.002_bib0016","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/15598276231212825","article-title":"The academic basis of lifestyle medicine","volume":"18","author":"Rippe","year":"2024","journal-title":"Am J Lifestyle Med"},{"issue":"4","key":"10.1016\/j.jacl.2025.06.002_bib0017","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jacl.2023.05.099","article-title":"Nutrition interventions for adults with dyslipidemia: a clinical perspective from the National Lipid Association","volume":"17","author":"Kirkpatrick","year":"2023","journal-title":"J Clin Lipidol"},{"issue":"9841","key":"10.1016\/j.jacl.2025.06.002_bib0018","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jacl.2025.06.002_bib0019","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jacl.2022.05.068","article-title":"NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient","volume":"16","author":"Cheeley","year":"2022","journal-title":"J Clin Lipidol"},{"issue":"9","key":"10.1016\/j.jacl.2025.06.002_bib0020","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.clinthera.2019.06.012","article-title":"Serious adverse effects of extended-release niacin\/laropiprant: results from the Heart Protection Study 2\u2013Treatment of HDL to reduce the incidence of vascular events (HPS2-THRIVE) trial","volume":"41","author":"Haynes","year":"2019","journal-title":"Clin Therap"},{"issue":"1","key":"10.1016\/j.jacl.2025.06.002_bib0021","first-page":"4","article-title":"The evolving role of bile acid sequestrants in lipid-lowering therapy","volume":"16","author":"Rosenson","year":"2022","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1016\/j.jacl.2025.06.002_bib0022","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.jacl.2025.06.002_bib0023","first-page":"80","article-title":"Navigating cardiovascular risk and Lipid management in Indian patients: key messages from the Lipid Association of India 2024 consensus Statement IV","volume":"72","author":"Puri","year":"2024","journal-title":"J Assoc Phys India"},{"key":"10.1016\/j.jacl.2025.06.002_bib0024","unstructured":"American Board of Clinical Lipidology (ABCL). \u201cFind a specialist.\u201d LipidBoard.org, https:\/\/www.lipidboard.org\/find-a-diplomate\/. Accessed May 4, 2025."}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425003174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425003174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:57:47Z","timestamp":1761364667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287425003174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":24,"alternative-id":["S1933287425003174"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2025.06.002","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LDL cholesterol management simplified in adults\u2014Lower for longer is better: Guidance from the National Lipid Association","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2025.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 National Lipid Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}